Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
09/04/2013 | EP2632453A1 Nitric oxide amino acid esters for improving vascular circulation, and prophylaxis or treatment of a condition associated with impaired blood circulation |
09/04/2013 | EP2632450A1 Compositions comprising a taxane for coating medical devices |
09/04/2013 | EP2632255A1 Diazeniumdiolate heterocyclic derivatives |
09/04/2013 | EP2374798B1 Benzazepine derivatives useful as vasopressin antagonists |
09/04/2013 | CN103282041A Extract of aerial parts of maca rich in polyphenols and composition comprising same |
09/04/2013 | CN103282027A Pharmaceutical composite formulation comprising hmg-oa reductase inhibitor and aspirin |
09/04/2013 | CN103276015A Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
09/04/2013 | CN103275984A MCP-1 binding nucleic acids |
09/04/2013 | CN103275901A Space-induced efficient bacillus natto, application of bacillus natto and preparation method of troche of bacillus natto |
09/04/2013 | CN103275856A Health liquor |
09/04/2013 | CN103275221A Human antibodies that bind human tnf alpha |
09/04/2013 | CN103275186A Polypeptide having kidney protection effect, and application thereof |
09/04/2013 | CN103275181A Tuna ground meat polypeptide angiogenesis inhibiting factor as well as preparation method and application thereof |
09/04/2013 | CN103275179A Small peptide reducing blood pressure and having renin and ACE double inhibitory activity, and preparation method and application of small peptide |
09/04/2013 | CN103275177A Small peptide having renin and ACE double inhibitory activity, and preparation method and application of small peptide |
09/04/2013 | CN103275148A Preparation method of icariin |
09/04/2013 | CN103275074A Olmesartan derivative and preparation method thereof |
09/04/2013 | CN103272236A Beta-adrenergic receptor retarder and vitamins B-containing pharmaceutical composition and applications thereof |
09/04/2013 | CN103272235A Pharmaceutical composition for preventing or treating cold injury and thrombus |
09/04/2013 | CN103272225A Crystallized oxalate decarboxylase and methods of use |
09/04/2013 | CN103272219A Selective r-cadherin antagonists and methods |
09/04/2013 | CN103272188A Agent for curing sequelae of apoplexy |
09/04/2013 | CN103272185A Agent for curing cardiovascular and cerebrovascular diseases |
09/04/2013 | CN103272176A Traditional Chinese medicine composition for treating cardiovascular disease and preparation method thereof |
09/04/2013 | CN103272175A Traditional Chinese medicine for treating myocardial infarction and preparation method thereof |
09/04/2013 | CN103272174A Application of drug in treatment of coronary heart disease |
09/04/2013 | CN103272118A Chinese herba preparation for treating hypertension and preparation method of Chinese herba preparation |
09/04/2013 | CN103272092A Huoxiang Zhengqi externally-applied preparation and its preparation method and application |
09/04/2013 | CN103272090A Traditional Chinese medicine oral liquid for treating broiler ascites |
09/04/2013 | CN103272082A Preparation method of traditional Chinese medicine decoction for treating pulmonary hypertension |
09/04/2013 | CN103272071A Grape extract, dietary supplement thereof, and processes therefor |
09/04/2013 | CN103272065A Method for extracting volatile oil from agilawood seeds, and usage and application of volatile oil |
09/04/2013 | CN103272042A Smoked lotion for treating hemorrhoids and fistula |
09/04/2013 | CN103272041A Traditional Chinese medicine composition for treating haemorrhoids |
09/04/2013 | CN103272035A Sphacelus treatment medicine |
09/04/2013 | CN103272029A Traditional Chinese medicine formula for curing hypertension |
09/04/2013 | CN103272019A Traditional Chinese medicinal composition for treating wind-heat and intestine-dryness type haememorrhoids |
09/04/2013 | CN103272012A Aconite and licorice extractive as well as preparation method and application thereof |
09/04/2013 | CN103272009A Medicine for treating cardiovascular and cerebrovascular diseases and preparation method of medicine |
09/04/2013 | CN103272002A Traditional Chinese medicine compound preparation for treating chicken ascites syndrome and preparation method thereof |
09/04/2013 | CN103271988A Method for preparing crudely-extracted lavender liquid and application of crudely-extracted liquid |
09/04/2013 | CN103271981A Yufengningxin (medicine name) soft capsule and preparation method thereof |
09/04/2013 | CN103271935A Use of poloxamer for the prevention and/or treatment of heart failure |
09/04/2013 | CN103271930A Pharmaceutical composition for treating diabetic feet caused by diabetes and acro-skin lesion and preparation method of pharmaceutical composition |
09/04/2013 | CN103271926A Compound combination containing left-handed amlodipine mesylate and used for curing hypertension |
09/04/2013 | CN103271908A Oral tablet containing telmisartan and amlodipine besylate and preparation method thereof |
09/04/2013 | CN103271904A Nitric oxide donor endothelin receptor antagonist as well as preparation method and application thereof |
09/04/2013 | CN103271896A Preparation method of stable calcium dobesilate |
09/04/2013 | CN103271895A Stable calcium dobesilate containing pharmaceutical composition and preparation method thereof |
09/04/2013 | CN103271893A Preparation method for lycopene microcapsule |
09/04/2013 | CN103271506A Depressurization healthcare shoe |
09/04/2013 | CN102836320B Chinese medicinal pill for treating tachyarrhythmia |
09/04/2013 | CN102743539B Traditional Chinese medicine for treating coronary heart disease with warming yang and promoting blood circulation effects, and preparation method for same |
09/04/2013 | CN102743482B Traditional Chinese medicine for preventing postpartum pulmonary embolism |
09/04/2013 | CN102657875B ANT1 gene-based targeted immunoliposome, preparation method thereof and application thereof |
09/04/2013 | CN102526673B Chinese medicine capsule, Chinese medicine liquid and health-care oral liquid for treating dilated cardiomyopathy and manufacture method |
09/04/2013 | CN102526317B Chinese medicine applying agent for treating bedsore |
09/04/2013 | CN102463102B Surface-bonded baicalin magnetic nano-particle, and preparation method and application thereof |
09/04/2013 | CN102389416B Application of farrerol, derivative thereof and pharmaceutically-acceptable salts of farrerol and derivative in preparing medicine for treating heart cerebrovascular disease caused by vasoconstriction |
09/04/2013 | CN102358735B Low toxicity multiple-point guided drug, nitrogen-containing aromatic ring CB1 receptor inhibitor with hydroxyl or substituted hydroxyl, and pharmaceutical use thereof |
09/04/2013 | CN102225913B Rheinic acid derivatives and treatment application thereof |
09/04/2013 | CN102127165B Production process for preparing high-purity ApoA-I (Apolipoprotein A-I) from precipitates of plasma fraction IV |
09/04/2013 | CN102028742B Drug for treating coronary heart disease and extraction method thereof |
09/04/2013 | CN102028741B Medicament for treating coronary heart disease and extraction thereof |
09/04/2013 | CN101837003B Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
09/04/2013 | CN101797386B Novel nerve protective agent |
09/04/2013 | CN101646669B Purinyl derivatives and their use as potassium channel modulators |
09/04/2013 | CN101646442B Therapeutic or prophylactic agent for vasoconstriction |
09/04/2013 | CN101544596B Preferred crystal-form substance of nitrendipine and preparation method, pharmaceutical composition and application thereof |
09/04/2013 | CN101460188B Treatment of ischemic disease using erythropoietin |
09/03/2013 | US8524729 Cinnamoyl derivatives and use thereof |
09/03/2013 | US8524721 Platelet ADP receptor inhibitors |
09/03/2013 | US8524711 Amino-derivatives as novel inhibitors of histone deacetylase |
09/03/2013 | US8524446 Method for detecting adeno-associated virus |
09/03/2013 | US8524229 Medicament and a method for regulation of the vascular tone |
09/03/2013 | CA2707767C Biologically active peptides |
09/03/2013 | CA2595182C Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith |
09/03/2013 | CA2565029C Immediate release pharmaceutical tablets with height greater than width |
09/03/2013 | CA2241564C Wsx receptor and ligands |
08/29/2013 | WO2013126438A1 Sulfinylbenzyl and thiobenzyl derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
08/29/2013 | WO2013126428A1 Phenoxy derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
08/29/2013 | WO2013126384A1 Cardio-protective agents from kiwifruits |
08/29/2013 | WO2013126368A1 Methods, assays, and systems relating to sakt |
08/29/2013 | WO2013126006A1 Polypeptides binding to human complement c5 |
08/29/2013 | WO2013124791A1 Solid form of bosentan |
08/29/2013 | WO2013124748A1 Novel polymorphs of azilsartan medoxomil potassium |
08/29/2013 | WO2013124382A1 Peltatin for use in the treatment of cardiovascular disorders |
08/29/2013 | WO2013124025A1 Furopyridine derivatives |
08/29/2013 | WO2013123996A1 Novel sirna inhibitors of human icam-1 |
08/29/2013 | US20130225643 Endogeneous repair factor production accelerators |
08/29/2013 | US20130225607 Method for treating a pulmonary hypertension condition without companion diagnosis |
08/29/2013 | US20130224306 Method for treating a pulmonary hypertension condition without companion diagnosis |
08/29/2013 | US20130224189 Tweak receptor |
08/28/2013 | EP2630144A1 Rho kinase inhibitors |
08/28/2013 | EP2630141A1 Cathepsin s inhibitor compounds |
08/28/2013 | EP2629787A1 Selective targeting of the cd40l/mac-1 interaction by small peptide inhibitors and its use for the treatment of inflammation and atherogenesis |
08/28/2013 | EP2629776A2 Compounds, compositions and methods useful for cholesterol mobilisation |
08/28/2013 | EP2629632A1 Formulation comprising arginine, use and preparation thereof |
08/28/2013 | CN203154347U Hemorrhoids suppository |
08/28/2013 | CN1538951B Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of chemotaxis of polymorphonucleate and mononucleate cells |